Comparing OptimizeRx (NASDAQ:OPRX) and Adobe (NASDAQ:ADBE)

OptimizeRx (NASDAQ:OPRXGet Free Report) and Adobe (NASDAQ:ADBEGet Free Report) are both computer and technology companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, analyst recommendations, earnings, dividends and profitability.

Valuation & Earnings

This table compares OptimizeRx and Adobe”s revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
OptimizeRx $109.43 million 1.02 $5.13 million $0.26 22.81
Adobe $23.77 billion 4.08 $7.13 billion $17.17 13.98

Adobe has higher revenue and earnings than OptimizeRx. Adobe is trading at a lower price-to-earnings ratio than OptimizeRx, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares OptimizeRx and Adobe’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
OptimizeRx 4.69% 10.61% 7.54%
Adobe 29.48% 64.48% 25.71%

Volatility & Risk

OptimizeRx has a beta of 1.28, indicating that its stock price is 28% more volatile than the S&P 500. Comparatively, Adobe has a beta of 1.52, indicating that its stock price is 52% more volatile than the S&P 500.

Insider & Institutional Ownership

76.5% of OptimizeRx shares are owned by institutional investors. Comparatively, 81.8% of Adobe shares are owned by institutional investors. 5.6% of OptimizeRx shares are owned by company insiders. Comparatively, 0.2% of Adobe shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Analyst Ratings

This is a summary of current recommendations and price targets for OptimizeRx and Adobe, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OptimizeRx 1 1 6 1 2.78
Adobe 5 15 10 1 2.23

OptimizeRx presently has a consensus target price of $17.57, suggesting a potential upside of 196.31%. Adobe has a consensus target price of $343.88, suggesting a potential upside of 43.22%. Given OptimizeRx’s stronger consensus rating and higher probable upside, equities analysts plainly believe OptimizeRx is more favorable than Adobe.

Summary

Adobe beats OptimizeRx on 10 of the 14 factors compared between the two stocks.

About OptimizeRx

(Get Free Report)

OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.

About Adobe

(Get Free Report)

Adobe Inc., together with its subsidiaries, operates as a diversified software company worldwide. It operates through three segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products, services, and solutions that enable individuals, teams, and enterprises to create, publish, and promote content; and Document Cloud, a unified cloud-based document services platform. Its flagship product is Creative Cloud, a subscription service that allows members to access its creative products. This segment serves content creators, students, workers, marketers, educators, enthusiasts, and communicators. The Digital Experience segment provides an integrated platform and set of applications and services that enable brands and businesses to create, manage, execute, measure, monetize, and optimize customer experiences from analytics to commerce. This segment serves marketers, advertisers, agencies, publishers, merchandisers, merchants, web analysts, data scientists, developers, and executives across the C-suite. The Publishing and Advertising segment offers products and services, such as e-learning solutions, technical document publishing, web conferencing, document and forms platform, web application development, and high-end printing, as well as Advertising Cloud offerings. It also provides consulting, technical support, and learning services. The company offers its products and services directly to enterprise customers through its sales force and local field offices, as well as to end users through app stores and through its website at adobe.com. It also distributes products and services through distributors, value-added resellers, systems integrators, software vendors and developers, retailers, and original equipment manufacturers. The company was formerly known as Adobe Systems Incorporated and changed its name to Adobe Inc. in October 2018. Adobe Inc. was founded in 1982 and is headquartered in San Jose, California.

Receive News & Ratings for OptimizeRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptimizeRx and related companies with MarketBeat.com's FREE daily email newsletter.